Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study

We analyzed the treatment responses, toxicities, and survival outcomes of patients with relapsed or refractory multiple myeloma who received daily thalidomide, cyclophosphamide, and dexamethasone (CTD) or daily thalidomide, melphalan, and prednisolone (MTP) at 17 medical centers in Korea. Three‐hund...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Jihyun, Min, Chang‐Ki, Kim, Kihyun, Han, Jae‐joon, Moon, Joon Ho, Kang, Hye Jin, Eom, Hyeon‐Seok, Kim, Min Kyoung, Kim, Hyo Jung, Yoon, Dok Hyun, Lee, Jeong‐Ok, Lee, Won Sik, Lee, Jae Hoon, Lee, Je‐Jung, Choi, Yoon‐seok, Kim, Sung hyun, Yoon, Sung‐soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269709/
https://www.ncbi.nlm.nih.gov/pubmed/27905203
http://dx.doi.org/10.1002/cam4.970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269709/
https://www.ncbi.nlm.nih.gov/pubmed/27905203
http://dx.doi.org/10.1002/cam4.970

Ejemplares similares